Share
When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
Manage episode 519906913 series 3381584
Content provided by Petauri Evidence. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Petauri Evidence or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
What does the evolving NHS landscape look like through the eyes of a Chief Pharmacist, and how are integrated care system (ICS) pharmacy teams responding?
In this Petauri Evidence NHS Whispers session, we put your questions to Yousaf Ahmad (Chief Pharmacist and Director of Medicines Optimisation, Frimley ICS), as he shares how he and his colleagues are responding to the changing NHS environment. From system pressures and financial constraints to prescribing priorities and service redesign, Yousaf explored how ICS pharmacy teams are adapting, and what this means for industry partners.
This episode was first broadcast as live webinar on: Friday 24th October 2025.
Learn more about this episode at https://petauri.com/insights/evolving-nhs-ics-chief-pharmacists-perspective/
Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence
Chapters
1. Welcome and Introductions (00:00:00)
2. How are things going in your world right now? (00:02:25)
3. How will ICS structural changes shape healthcare delivery? (00:03:32)
4. What challenges do ICBs face in taking on specialist services? (00:05:42)
5. How is the NHS 10-Year Plan influencing high-cost drug prescribing? (00:07:19)
6. How will medicines optimisation evolve within ICBs? (00:10:33)
7. Where will prescribing budgets sit under the neighbourhood model? (00:14:32)
8. Do you have a preferred model for budget management? (00:17:53)
9. How might confidential pricing arrangements be managed? (00:20:03)
10. What defines a productive relationship with pharmaceutical suppliers? (00:21:40)
11. What types of engagement or evidence sharing are most valuable? (00:24:55)
12. What are the benefits and risks of a single national formulary? (00:26:14)
13. Closing Remarks and Contact Information (00:30:25)
72 episodes
))
